transcatheter aortic valve replacement (TAVR)

21-HVI-2035428-high-deployment-SAPIEN-3_650x450

January 21, 2021/Heart, Vascular and Thoracic/Heart Valve Disease

Higher Positioning of SAPIEN 3 Valve Reduces Conduction Abnormalities and Pacemaker Requirements

Novel TAVR deployment technique improves outcomes without compromising safety

November 19, 2020/Heart, Vascular and Thoracic/Research

Recent U.S. Progress Against Aortic Stenosis Mortality Has Not Been Uniform

Nationwide database study finds racial and regional variations

October 12, 2020/Heart, Vascular and Thoracic/Research

TAVR More Apt to Help Than Harm in CKD, PARTNER Subanalysis Shows

Findings offer reassurance, clarify understanding of cardiorenal syndrome

August 5, 2020/Heart, Vascular and Thoracic/Research

Stroke Reduction in TAVR Patients: Clearer Answers Are on the Horizon

Insights on the PROTECTED TAVR and WATCH-TAVR trials

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 17, 2019/Heart, Vascular and Thoracic/Research

Survival After TAVR Better in Patients with Mixed Aortic Valve Disease Vs. Pure Aortic Stenosis

Cohort study provides insights on TAVR in an understudied group

October 16, 2019/Heart, Vascular and Thoracic/Research

PCI Does Not Impact Clinical Outcomes in Patients Undergoing TAVR, Meta-Analysis Finds

Pooled results of 11 observational studies offer needed guidance on PCI in this setting

19-HRT-4026 Kapadia_stroke-risk-TAVR-650×450

August 1, 2019/Heart, Vascular and Thoracic/Research

Stroke Rates During First 5 Years of the TAVR Era: Low but Stubbornly Stable

30-day risk assessed among 100,000+ TAVR patients in U.S.

March 16, 2019/Heart, Vascular and Thoracic/Research

TAVR Yields Similar Outcomes to SAVR at 1 Year in Patients at Low Surgical Risk

PARTNER 3 and CoreValve Low Risk reveal pros and cons of both approaches

February 11, 2019/Heart, Vascular and Thoracic/Research

RAS Inhibitors After TAVR Improve 1-Year Outcomes in Retrospective Cohort Study

Surprisingly, biggest effect seen in patients with preserved LVEF

October 22, 2018/Heart, Vascular and Thoracic/Insight & Perspectives

3 Things to Keep an Eye on in Evolving TAVR Care

Expanding indications, device refinements and accessory treatments

Tag: transcatheter aortic valve replacement (TAVR)